267 related articles for article (PubMed ID: 7010382)
41. Bronchoneutral effects in hypertensive asthmatics--celiprolol versus chlorthalidone.
Dorow P
J Int Med Res; 1988; 16 Suppl 1():23A-26A. PubMed ID: 2975609
[TBL] [Abstract][Full Text] [Related]
42. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
43. Effects of two doses of the fixed-combination chlorthalidone and slow-release metoprolol on blood pressure at rest and during exercise: a multicenter study.
Caponnetto S; Alberti D; Bafico GL; Bertulla A; Camerieri A; Francucci BM; Gatto E; Gentile A; Livi S; Mereto PE
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):574-9. PubMed ID: 3781678
[TBL] [Abstract][Full Text] [Related]
44. The neglected time factor and antihypertensive therapy. A pitfall in evaluating side effects in a cross-over study.
Edmonds D; Greminger P; Vetter W; Baumgart P; Vetter H
Postgrad Med; 1988 Feb; Spec No():40-5. PubMed ID: 2831525
[TBL] [Abstract][Full Text] [Related]
45. Atenolol improves blood pressure control in patients taking captopril and frusemide.
Potter JF; Beevers DG
J Hum Hypertens; 1987 Sep; 1(2):127-30. PubMed ID: 3333524
[TBL] [Abstract][Full Text] [Related]
46. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA; Punzi CF
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[TBL] [Abstract][Full Text] [Related]
47. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
48. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
49. Chronic treatment with tibalosine in essential hypertension.
Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A
Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
51. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Waeber B
J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
[TBL] [Abstract][Full Text] [Related]
52. [Double-blind comparative study of the hypotensive effect of combination therapy with chlorthalidone and metoprolol or alpha-methyldopa].
Guidi G; Giuntoli F; Galeone F; Checchi M; Locci P; Saba GC; Saba P
G Clin Med; 1981 Aug; 62(8):558-66. PubMed ID: 7030853
[No Abstract] [Full Text] [Related]
53. [Treatment of hypertension with a new beta blocker-diuretic combination under long-term control].
Hoffmann H; Hoffmann W
Wien Med Wochenschr; 1985 Mar; 135(5):127-34. PubMed ID: 2859703
[TBL] [Abstract][Full Text] [Related]
54. Hypertension in the elderly: a study of a combination of atenolol and nifedipine.
Duckett GK; Cheadle B
Br J Clin Pract; 1990 Feb; 44(2):52-4. PubMed ID: 2200490
[TBL] [Abstract][Full Text] [Related]
55. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
[TBL] [Abstract][Full Text] [Related]
56. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
Karachalios GN
Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
[TBL] [Abstract][Full Text] [Related]
57. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
58. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
59. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
60. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
Sourgens H; Schmidt J; Derendorf H
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
